{
  "id": 15601715,
  "title": "Is UnitedHealth Group Stock a Buy After Another Solid Quarter?",
  "url": "https://urgent.news/2026/10/19/is-unitedhealth-group-stock-a-buy-after-another-solid-quarter",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-19T12:00:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/19/is-unitedhealth-group-stock-a-buy-after-another-solid-quarter/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "UnitedHealth Group (UNH) has recently posted a robust quarter, with revenue reaching $112.7 billion, surpassing analysts' expectations of $111.4 billion for the period ending September 30th. Adjusted earnings per share (EPS) stood at $4.69, outperforming the forecasted $4.14. Consequently, the healthcare provider increased its guidance, anticipating adjusted EPS to be at least $20.50 for the year, an improvement from the previous range of $19.50 to $20. The company's strategic moves, including exiting unprofitable markets and investing in artificial intelligence (AI), have contributed to its improved financial performance. UnitedHealth's stock, trading at around $401, is currently relatively affordable, boasting a forward price-to-earnings multiple of approximately 16, which is lower than the S&P 500's average of over 19. With a dividend yielding 2.3%, UnitedHealth Group presents itself as a compelling long-term investment, offering both value and stability while providing attractive income for investors.",
  "summary": "The healthcare giant recently posted its third-quarter earnings, which came in better than expected.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}